These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Delavirdine expanded access program.
    Journal: BETA; 1996 Jun; ():7. PubMed ID: 11363651.
    Abstract:
    Upjohn Pharmacia started an expanded access program for delavirdine (Rescriptor) for patients with CD4 cell counts below 300 who are failing other therapies and receiving at least one other antiretroviral drug. Delavirdine, a non-nucleoside reverse transcriptase inhibitor, has been found to be synergistic with other antiretrovirals such as AZT and ddI.
    [Abstract] [Full Text] [Related] [New Search]